• Sectors we work in banner(2)

    Quick Reads

MTF admission prospectuses – what are they and why have they been “introduced” by POATR?

min read

The Public Offers and Admissions to Trading Regulations 2024 (POATR) are overhauling the UK's prospectus regime, effective 19 January 2026. POATR (and an accompanying raft of legislation) will replace the UK's prospectus regime, making it cheaper and easier for companies to raise capital in the UK and our markets more competitive. Follow our mini-series of articles on POATR for an idea of what to expect.

You could be forgiven for thinking that POATR had introduced a new, POATR specific, document when reading about an “MTF admission prospectus”. Panic not and read on!

What is an MTF?

An MTF or multilateral trading facility is a venue run by an exchange where companies can have their securities traded without being on the main regulated market (i.e. the Main Market of the London Stock Exchange). Under POATR, a venue counts as a “primary MTF” if it maintains and enforces clear rules on who can list, what must be published to list, and what must be kept up to date after listing. Both AIM and the Aquis Growth Market are treated as primary MTFs under POATR.

What is an MTF admission prospectus?

An MTF admission prospectus is, simply, the document that a company publishes when it seeks to list its shares on a UK primary MTF. So, using AIM as an example, the “MTF admission prospectus” is simply the AIM Admission Document already required by the AIM Rules for Companies. Happily, there is no need for an additional document to be prepared! However, an MTF admission prospectus is required to satisfy the statutory “necessary information” test under POATR and is subject to the statutory prospectus responsibility and compensation regime. An MTF admission prospectus will be required on a company’s initial admission to trading and for reverse takeovers (simplified admission routes not currently requiring an admission document will be exempted). 

An MTF admission prospectus is not reviewed or approved by the Financial Conduct Authority (FCA). It is prepared to meet the relevant venue’s standards and is assessed by the venue itself and the company’s advisers. By contrast, a prospectus is an FCA‑approved document used for listings on the Main Market of the London Stock Exchange. POATR preserves that prospectus regime for these more complex transactions.

Why did POATR “introduce” MTF admission prospectuses?

POATR’s aim in introducing MTF admission prospectuses is to remove uncertainty about when a full prospectus is needed. MTFs set and police admission‑stage disclosure for their markets; the FCA approves prospectuses for the Main Market of the London Stock Exchange and specified public offers only.

This matters for growth companies: venue‑level disclosure can be tailored, faster and more cost‑effective, supporting earlier‑stage businesses without diluting investor protections. Issuers on primary MTFs must still comply with the venue’s ongoing rules and market‑wide standards on fair disclosure and market abuse, and the FCA supervises the venues themselves. 

In short, POATR did not create a new layer of paperwork; it sought to clarify roles. MTF admission prospectuses remain venue‑driven and, generally, lighter touch, while the prospectus regime is focused where broad retail participation and higher regulatory formality justify FCA approval.

"The use of an MTF admission prospectus is intended to encourage wider participation in the ownership of public companies by enabling Primary MTF issuers to offer securities to a wide range of investors (ie not limited to qualified investors or to fewer than 150 persons) without the burden of having to produce an FCA-approved prospectus."

Our thinking

  • Charles Russell Speechlys advises Ulisses on €1 million seed round fundraising

    Annapaola Negri-Clementi

    News

    min read
  • Charles Russell Speechlys advises the shareholders of Pooky Lighting on its acquisition by leading US lighting company Visual Comfort & Co.

    David Coates

    News

    min read
  • Charles Russell Speechlys advises long standing client SPS on its acquisition of Cleardata

    Hamish Perry

    News

    min read
  • Charles Russell Speechlys awarded “Legal Advisers of the Year” at the HealthInvestor Awards 2026

    David Coates

    News

    min read
  • A founder's guide to SAFEs: fast-tracking investment for UK technology start-ups

    Grace Hudson

    Insights

    min read
  • Case No. 9. Can an arbitration clause be extended to a non-signatory party, and what are the relevant factors?

    Annapaola Negri-Clementi

    Insights

    min read
  • Top 5 things to consider when selling your Financial Services business

    Charlie Ring

    Insights

    min read
  • Ownership, Value and the Next Phase of African Investment

    Greg Stonefield

    Quick Reads

    min read
  • Investing in the UK Living Sector? Here’s what the latest regulatory changes mean

    Sarah Wigington

    Insights

    min read
  • Critical Minerals, Value Capture and the Next Phase of African Dealmaking

    Greg Stonefield

    Quick Reads

    min read
  • Africa M&A Is Recovering — But Execution Matters More Than Optimism

    Greg Stonefield

    Quick Reads

    min read
  • Charles Russell Speechlys appoints corporate and private equity specialist in London

    David Collins

    News

    min read
  • Erell Bauduin and Julia Landru publish in STEP Journal on family business succession planning in France

    Erell Bauduin

    In the Press

    min read
  • Charles Russell Speechlys advises RYDGE Conseil on its acquisition of Fiduciaire Cabexco and Cabexco Proactive

    Yacine Diallo

    News

    min read
  • Retail Collection: Business and Social Enterprise

    Iwan Thomas

    Podcasts

  • When Strategic Relevance Starts to Reshape Capital Markets

    Greg Stonefield

    Quick Reads

    min read
  • Charles Russell Speechlys has advised the founders of legal technology business, Obviously, on its sale to AIM listed RWS, a global AI solutions company

    Mark Howard

    News

    min read
  • Paula Boast MBE comments on the UK-GCC free trade agreement in Gulf Daily News

    Paula Boast MBE

    In the Press

    min read
  • Functional Food and Drink in 2025: Why Gut Health and Cognitive Performance are Driving UK M&A

    Imogen Brown

    Insights

    min read
  • Charles Russell Speechlys moves offices in Milan following consistent growth of Italian practice

    Michael Lingens

    News

    min read
Back to top